Biopharma appears to be changing at an exponential rate. We can help you jump-start your future.
Across Biopharma, you’ll find innovators who are developing therapies, treatments, and cures for society’s most pressing health challenges. Alongside them, you will find Deloitte. Leveraging more than 20 years of Biopharma experience, we connect the right people, partners, and technologies to orchestrate and deliver the business of science.
Hot off the press
Role of royalties in funding biopharma innovation
With biopharma innovation accelerating, funding models are rapidly evolving to meet rising capital demands. Drawing on insights from 100+ industry executives, our latest study explores how royalties are emerging as a strategic, non-dilutive source of capital to fuel the next wave of breakthroughs. Could this be the future of biopharma financing? Discover the key factors driving growing executive interest in royalty funding.
Insights and innovation
Biopharma services
Biopharma is transforming. This is an opportunity to lead the way. Combining deep industry experience and insights with advanced technologies and an ecosystem of alliances, Deloitte's biopharma consulting services deliver transformative strategies so you can usher in an era of greater efficiency, greater efficacy, and greater treatment personalization. Together, we can shape your approach to modernization, so that you can gain a competitive advantage and deliver a digitally enabled, equitable Future of Health™.
Deloitte has been recognized by the following
America’s Best Management Consulting Firms (Forbes 2022)
2023 Artificial Intelligence Excellence Award in Automation (The Business Intelligence Group 2023)
Deloitte Was Named a Leader in Life Sciences Smart Manufacturing Services by (Everest Group 2023)
Gartner Public Cloud IT Transformation Services Magic (Gartner 2022)
Gartner Data and Analytics Service Providers Magic (Gartner 2021)
Opens in new window
Industry leader
Deloitte Biopharma is the first choice for pharmaceutical and biotech organizations in need of effective strategies and end-to-end solutions for digital innovation across the value chain. Through cross-functional capabilities and cross-industry expertise, we bring cutting-edge practices and ideas to the table that address today’s business needs while positioning you for the future.
In 2023, Deloitte Life Sciences served
100% of the 10 largest global pharma companies (FiercePharma)
90% of the 10 largest Biotech companies (Genedge news)
100% of the top-10 medical device companies (MPO Magazine)
Andrew Bolt
